From Breast to Sclera: A Silent and Devastating Invasion

Aim: This case report highlights about a silent and devastating invasion of Scleral metastases. Introduction: Ocular metastases remain a rare manifestation of systemic malignancies. Scleral involvement is an exceptionally uncommon presentation, often mimicking inflammatory conditions, which may delay diagnosis and management. Case Presentation: We present the case of a 48-year-old woman with a history of left breast invasive ductal carcinoma diagnosed three years earlier. She underwent conservative treatment, lymph node dissection, chemotherapy, radiotherapy, and was maintained on Tamoxifen. She consulted the emergency department for a painful red left eye evolving over three days. Ophthalmologic examination revealed an 8/10 best-corrected visual acuity, a firm scleral nodule with vascular disorganization, and dilated scleral vessels. Systemic workup showed multiple cutaneous nodules, left pleural effusion, and axillary lymphadenopathy. Histopathological examination confirmed metastatic involvement of the sclera from breast carcinoma. Despite corticosteroid therapy, the lesion progressed. Imaging revealed multiple pulmonary metastases and an intra-auricular thrombus, leading to comprehensive oncologic management. Discussion: Scleral metastases are extremely rare and often masquerade as nodular scleritis. The presence of a treatment-resistant scleral nodule in a neoplastic context should raise suspicion of secondary malignancy. A biopsy is crucial to confirm the diagnosis and initiate timely oncologic care. Conclusion: Although uncommon, scleral metastasis should always be considered in patients with a history of malignancy presenting with atypical ocular symptoms. Early recognition can improve overall prognosis and quality of life.

Authors

Publication Details

Journal
Ophthalmology Research An International Journal
Published
2025-05-06
DOI
https://doi.org/10.9734/or/2025/v20i2453
Primary Topic
Health and Conflict Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From Breast to Sclera: A Silent and Devastating Invasion

Y. EL KHALIFA, abdeljalil Moutaouakil, I. HAJJI, S. Belghmaidi et al.
Ophthalmology Research An International Journal
Health and Conflict Studies
article

From Breast to Sclera: A Silent and Devastating Invasion

Y. EL KHALIFA, abdeljalil Moutaouakil, I. HAJJI, S. Belghmaidi, S. Rachda
article en

Abstract

Aim: This case report highlights about a silent and devastating invasion of Scleral metastases. Introduction: Ocular metastases remain a rare manifestation of systemic malignancies. Scleral involvement is an exceptionally uncommon presentation, often mimicking inflammatory conditions, which may delay diagnosis and management. Case Presentation: We present the case of a 48-year-old woman with a history of left breast invasive ductal carcinoma diagnosed three years earlier. She underwent conservative treatment, lymph node dissection, chemotherapy, radiotherapy, and was maintained on Tamoxifen. She consulted the emergency department for a painful red left eye evolving over three days. Ophthalmologic examination revealed an 8/10 best-corrected visual acuity, a firm scleral nodule with vascular disorganization, and dilated scleral vessels. Systemic workup showed multiple cutaneous nodules, left pleural effusion, and axillary lymphadenopathy. Histopathological examination confirmed metastatic involvement of the sclera from breast carcinoma. Despite corticosteroid therapy, the lesion progressed. Imaging revealed multiple pulmonary metastases and an intra-auricular thrombus, leading to comprehensive oncologic management. Discussion: Scleral metastases are extremely rare and often masquerade as nodular scleritis. The presence of a treatment-resistant scleral nodule in a neoplastic context should raise suspicion of secondary malignancy. A biopsy is crucial to confirm the diagnosis and initiate timely oncologic care. Conclusion: Although uncommon, scleral metastasis should always be considered in patients with a history of malignancy presenting with atypical ocular symptoms. Early recognition can improve overall prognosis and quality of life.

Ophthalmology Research An International JournalVol. 20(2)
Openalex Percentile: Top 84%
Health and Conflict Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.